KURADURA
Kuros Biosurgery AG
Application Filed: 2008-08-15
Trademark Application Details
IR CANCELLED; US REGISTRATION CANCELLED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79062235 |
| Registration Number | 3807132 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Cancellation Code | H |
| Law Office Assigned | M30 |
| Employee Name | MAHMOUDI, MARIAM AZIZ |
Timeline
| 2008-08-15 | Application Filed |
| 2010-04-06 | Published for Opposition |
| 2010-06-22 | Location: PUBLICATION AND ISSUE SECTION |
| 2010-06-22 | Trademark Registered |
| 2018-08-15 | Cancelled |
| 2018-08-15 | Status: Dead/Cancelled |
| 2019-03-16 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Kuros Biosurgery AG |
| Entity Statement | Aktiengesellschaft |
| Address | Wagistrasse 25 CH-8952 Schlieren CH |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| Type Code | Type |
|---|---|
| GS0051 | Cosmetic products, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cement, which contain hormones and/or growth factors to support restoration and reconstruction in reconstructive or cosmetic surgery; materials for permanent or temporary enlargement, filling, repair, stabilization, support and replication of endogenous soft tissue, in particular fatty tissue and muscle tissue, other than for medical purposes, namely, protein and/or peptide and/or polyalkylenoxide preparations; carrier materials of synthetic and/or natural origin for cosmetic purposes, namely, matrices, solutions, gels, pastes, microparticles, nanoparticles, beads and cements, in particular consisting of fibrin and/or polyethylene glycol for retention or increased release of peptides or proteins, in particular hormones and growth factors, i.e., substances which stimulate growth of an organism or maintain growth for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; pharmaceutical products and preparations, namely, protein and/or peptide preparations, in particular for locally supporting the formation or regeneration of missing or damaged body parts, in particular of hard or soft tissue, in particular skin or bone; pharmaceutical or medical formulations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements of synthetic and/or natural origin for medical purposes, namely, for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue, in particular comprising fibrin and/or polyoxyalkyleneoxides, namely, polyethylene glycol for retention or sustained release of peptides, proteins and/or allograft materials, in particular hormones, growth factors and/or demineralized bone matrix, i.e., substances which stimulate growth of an organism or maintain growth; healthcare preparations, namely, implants, coatings, creams, gels, solutions, pastes, beads, microparticles, nanoparticles and cements for use in reconstructive, regenerative, generative and cosmetic interventions for treatment of injured, diseased or degenerated tissue; biomedical products and biotechnology products for medical purposes, namely, peptides and proteins like hormones and growth factors or allograft materials used to spur regrowth and formation and to repair tissue, namely, tissue of bone, skin, organs, tendons, ligament, cartilage; materials for medical purposes for permanent or temporary enlargement, filling, repair, stabilization, support and/or regeneration of hard or soft tissue, in particular bone, intervertebral disk, cartilage, fatty tissue and muscle tissue, namely, protein and/or peptide and/or polyalkylenoxide preparations; biocompatible permanent or temporary adhesives and sealants, in particular for human and animal organs, soft and hard tissue for medical purposes; biocompatible separating materials, namely, anti-adhesion materials for avoiding undesired adhesion of organs and/or soft parts for medical purposes; implants and transplants of human derived autologous or allograft materials; autologous and allograft soft tissue for cosmetic and medical purposes; autologous and allograft hard and soft tissue in particular bone for transplantation purposes, bone replacement, cartilage replacement, vessel replacement, tissue replacement and fatty tissue replacement |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2008-12-18 | 1 REPR M: |
| NEW APPLICATION ENTERED IN TRAM | 2008-12-19 | 2 NWAP I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2008-12-19 | 3 DOCK D:Assigned to Examiner |
| APPLICATION FILING RECEIPT MAILED | 2008-12-23 | 4 MAFR O:Outgoing Correspondence |
| NON-FINAL ACTION WRITTEN | 2009-01-02 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2009-01-03 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2009-01-06 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2009-01-06 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2009-02-06 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2009-07-06 | 10 TROA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2009-07-06 | 11 TCCA I:Incoming Correspondence |
| ASSIGNED TO LIE | 2009-07-21 | 12 ALIE A:Allowance for Publication |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2009-07-21 | 13 CHAN I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2009-07-21 | 14 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2009-07-21 | 15 TEME I:Incoming Correspondence |
| FINAL REFUSAL WRITTEN | 2009-08-17 | 16 CNFR R:Renewal |
| FINAL REFUSAL E-MAILED | 2009-08-17 | 17 GNFR O:Outgoing Correspondence |
| NOTIFICATION OF FINAL REFUSAL EMAILED | 2009-08-17 | 18 GNFN O:Outgoing Correspondence |
| EXPARTE APPEAL RECEIVED AT TTAB | 2010-02-12 | 19 EXAF T:TTAB Proceeding |
| JURISDICTION RESTORED TO EXAMINING ATTORNEY | 2010-02-12 | 20 JURT T:TTAB Proceeding |
| EX PARTE APPEAL-INSTITUTED | 2010-02-12 | 21 EXPI T:TTAB Proceeding |
| TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2010-02-12 | 22 ERFR I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2010-02-16 | 23 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2010-02-16 | 24 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2010-02-16 | 25 CNSA O:Outgoing Correspondence |
| EXPARTE APPEAL TERMINATED | 2010-02-25 | 26 EXPT T:TTAB Proceeding |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2010-03-01 | 27 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2010-04-06 | 28 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2010-04-06 | 29 NPUB E:E-Mail |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2010-05-20 | 30 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2010-05-20 | 31 OPNS P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2010-06-04 | 32 OPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2010-06-22 | 33 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2010-09-22 | 34 FICR P: |
| FINAL DISPOSITION PROCESSED | 2010-09-24 | 35 FIMP P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2010-09-24 | 36 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2013-05-18 | 37 FINO P: |
| CANCELLED SECTION 71 | 2017-01-27 | 38 C71T O:Outgoing Correspondence |
| TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | 2017-09-27 | 39 INTR P: |
| INVALIDATION PROCESSED | 2017-10-02 | 40 INPC P: |
| TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | 2017-10-02 | 41 INTS P: |
| TOTAL INVALIDATION PROCESSED BY THE IB | 2017-10-27 | 42 INNT P: |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2018-01-25 | 43 ADCH M: |
| DEATH OF INTERNATIONAL REGISTRATION | 2019-03-15 | 44 DETH P: |
| NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | 2019-03-15 | 45 DENC O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 